Opana ER (extended-release oxymorphone) is a powerful opioid analgesic prescribed for managing severe, around-the-clock pain that requires long-term treatment. It is intended for patients who need continuous pain relief and have developed tolerance to other opioid medications.

 

Opana ER works by binding to specific receptors in the brain and spinal cord to alter the perception of pain, providing significant relief for chronic pain conditions. Due to its potency, Opana ER carries a high risk of addiction, abuse, and misuse, which can lead to overdose and death.

 

Therefore, it is typically prescribed only when alternative treatments are inadequate. The medication comes in tablet form and is designed to be taken orally without crushing, chewing, or dissolving, as altering the tablet can result in a potentially fatal dose.